blog

Guest Spotlight: Annie Finstein A Message to the Medical Community

By Beth Davis Heppenstall on Tue, Feb 5, 2019 | 5 min read

Rounding out our Study Voices panel for BBK's keynote “Do Engagement Tools Live Up to Their Hype?” is panelist, Annie Finstein. She is looking forward to sharing her experience as a patient and participant in a clinical research study on February 19 at the SCOPE conference. 

Annie was diagnosed with Crohn's disease in 2000 at nine years old. After trying all available medications approved for pediatric patients at that time, she participated in a pediatric study at Massachusetts General Hospital in Boston. Now in her late 20s, she enjoys spending time at the beach, hiking, cooking and gardening at her home in Boston. Annie is committed to making a difference and connects with other patients impacted by Crohn’s disease by running half marathons with Team Challenge, the Crohn's & Colitis Foundation’s endurance training and fundraising program.Annie_Finstein

What was most rewarding to you as a participant in a clinical research study?

It was most rewarding to know that I was helping advance the treatment of Crohn’s disease for pediatric patients, and that my participation might not only help me but also other kids suffering from inflammatory bowel disease (IBD).

Topics: Patient Recruitment, Patient Retention, BBK Worldwide, Patient Engagement, Patient Centricity, Conferences, Patient Experience, Patient, clinical trials, Patient Advocacy

Guest Spotlight: Gerald Dryden Site Feasibility and Protocol Design

By Beth Davis Heppenstall on Fri, Feb 1, 2019 | 5 min read

BBK’s signature Pharma15 Live! web series is coming to the 10th Annual SCOPE Summit for Clinical Ops Executives. On February 19, Bonnie A. Brescia, BBK’s founding principal, will moderate a panel during the conference’s plenary keynote program on the topic of “Do Engagement Tools Live Up to Their Hype?” 

We are pleased to introduce one of our panelists, Gerald Wayne Dryden, Jr., MD, PhD, MSPH, MSc of University of Louisville, Kentucky.

Dr. Gerald Dryden

Dr. Gerald “Tad” Dryden is Professor of Medicine and Director of the Inflammatory Bowel Disease Program in the Division of Gastroenterology at the University of Louisville in Louisville, KY.  He earned his MD at the University of Kentucky College of Medicine in Lexington, KY, and completed his internal medicine internship and residency at the Naval Medical Center in Portsmouth, VA. He then completed his gastroenterology fellowship at the Naval Medical Center in San Diego, CA.  During his tenure at the University of Louisville, he earned a Master of Science in Public Health, a Master of Science in Microbiology and Immunology, and a PhD in Microbiology and Immunology. Dr. Dryden’s research interests include developing new therapies from botanical sources and new medical devices to improve endoscopic care.

What is most rewarding to you as you consider your contribution to clinical trial research?

It is very rewarding when I am involved with a drug from the ground up -- seeing research patients benefit from the drug, then eventually being able to prescribe it to my clinic patients.

Topics: Patient Recruitment, Patient Retention, Patient Engagement, Pharma15, Patient, Site Support, Physician Referrals, Patient Experience

New eBook: Why and How Emerging Biopharmaceutical Companies Can Do More with Less

By Aaron Fleishman on Tue, Jan 15, 2019 | 1 min read

Ensuring Successful Enrollment of Your Clinical Trials

The market has never been more competitive for small- and mid-size biopharmaceutical companies. While your company may not have the resources or depth of experience as the larger companies, with the right strategies you can find yourself better positioned to deliver results faster and with less expense to reach your clinical trial enrollment goals.

In this free, downloadable ebook, we offer solutions 

Topics: global patient recruitment, Technology, eBook, BBK Worldwide, Patient Recruitment, Patient Retention, Patient Engagement, Trends

Uber, Lyft, and Emergency Care: CEO of BBK Worldwide, Joan F. Bachenheimer Responds to The New York Times

By Joan F. Bachenheimer on Thu, Oct 18, 2018 | 4 min read

You might have seen an article in the October 1 issue of The New York Times, titled “Uber, Lyft and the Urgency of Saving Money on Ambulances,” by Austin Frakt. The article pushed for alternative modes of transportation in medical situations – such as Uber and Lyft – as cost-saving measures.

CEO and Founding Principal of BBK Worldwide, Joan F. Bachenheimer, wrote a strong response to the article, which has been submitted to the Times as a Letter to the Editor. We would love to hear your thoughts on possible use of ride-sharing apps like Uber or Lyft for emergency services.

 

Topics: Patient Experience, Patient Engagement, Patient Retention, Patient Travel

Maximizing Digital Patient Engagement: A Four Step Process

By BBK Worldwide on Thu, Aug 2, 2018 | 1 min read

The idea of “digital patient engagement” continues to be one of the hottest topics in the healthcare industry, and according to BBK Worldwide director of innovation Erica Mercado, everyone defines this term in different ways. For instance, apps, wearables, and digital outreach and messaging are all tactics that can be effectively deployed to keep patients engaged. But for Erica, truly effective digital patient engagement amounts to more than the sum of its parts.

Topics: Pharma15, Patient Experience, digital health, Patient Engagement, Vlog

Sponsor of Choice

By Matt Kibby on Mon, Oct 30, 2017 | 2 min read

In an age where patients have more choice about treatment options (just think about how the treatment guidelines have evolved for multiple sclerosis or rheumatoid arthritis in the last 10 years for example,) and more clinical trials are being conducted by fewer investigators, there has been a constant upward pressure on competition for clinical trial patients, even as sponsors and third party recruitment companies becomes more innovative and proactive in their approaches to marketing their trials.

Topics: clinical trials, clinical research, Site Engagement, Patient Engagement

Buy a Baker’s Dozen

By Joan F. Bachenheimer on Tue, Oct 17, 2017 | 4 min read

It’s clear that the clinical team for each study is tasked with creating and managing an individual study budget. The problem is one-off study purchases do not accrue the benefits of volume discounting. Of course, there are numerous and complicated financial arrangements sponsors make with service providers to create optimal rates for clinical trial support – but what about the simple construct of, “buy one shirt, get another for free?”

Topics: clinical research, clinical trials, Patient Engagement, Patient Recruitment

Patient and Site Engagement in the Age of Integration

By BBK on Thu, Jun 22, 2017 | 3 min read

At this stage in the evolution of mHealth, how do we make it easier for sites and patients to stay engaged with a clinical trial? In this interview, BBK Worldwide’s Erica Mercado provides her insights on mHealth user experience optimization, adaptive engagement strategies, and mHealth’s integrated future.

Topics: Patient Engagement, clinical trials, clinical research

A Caregiver's Perspective on Rare Disease Clinical Trials

By Juli Greenwood on Thu, Apr 27, 2017 | 4 min read

Supporting rare disease research is a big part of our work here at BBK and rare disease recruitment is an expertise that our sponsors and CRO customers have come to expect from us.

While progress has been made to improve the lives of patients with rare disorders, there is much that still needs to be done to reach patients, further research, find new treatments and improve outcomes. Our most recent eBook, “Rare Disease Research. What’s Next?” is a collection of insights from a variety of rare disease stakeholders, including Roberta Carson, Founder and President of Zaggo, Inc. – a national nonprofit devoted to helping patients and families be more engaged members of their medical teams.

Topics: Patient Advocacy, Patient Engagement, Patient Experience

New eBook: Rare Disease Research. What’s Next?

By BBK on Thu, Feb 23, 2017 | 2 min read

Nearly a year ago, we released our first guide on rare disease clinical research. In it, we were looking to address some important questions facing the people who are committed to improving the lives of patients with rare disorders. While much progress has been made, it is critical that those of us in the health care and life sciences industry remain keenly aware of all that’s being done to further research and improve outcomes. In our latest eBook, “Focus 5: Rare Disease Research. What’s Next?” we reached out to industry experts for their insights on this evolving clinical research landscape.

Topics: Rare Disease, clinical research, Patient Engagement, Patient Recruitment

 
Subscribe To Our Blog